Eagle Wins Orphan Drug Status In Row With FDA
A D.C. federal judge came down on the side of Eagle Pharmaceuticals Inc. on Friday, ordering the U.S. Food and Drug Administration to grant orphan drug exclusivity to the company's chemotherapy...To view the full article, register now.
Already a subscriber? Click here to view full article